title: Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney.
abstract: Uteroplacental insufficiency causes intrauterine growth retardation (IUGR), which is associated with adult onset diseases such as hypertension. Previous studies demonstrate that growth retardation in humans and rats decreases glomeruli number; however, the molecular mechanisms responsible for this reduction are unknown. Apoptosis plays a key role in renal organogenesis. We therefore hypothesized that the in utero deprivation associated with uteroplacental insufficiency decreases glomeruli, increases apoptosis, and alters the mRNA levels of key apoptosis-related proteins in full-term IUGR kidneys. To prove this hypothesis, we induced asymmetric IUGR through bilateral uterine artery ligation of the pregnant rat. We found that uteroplacental insufficiency significantly reduced glomeruli number while increasing TUNEL staining and caspase-3 activity in the IUGR kidney. A significant decrease in Bcl-2 mRNA and a significant increase in Bax and p53 mRNA further characterized the IUGR kidney. Because altered p53 CpG methylation affects p53 expression, we analyzed p53 promoter CpG methylation using methylation-sensitive restriction enzymes and real-time PCR. Uteroplacental insufficiency specifically decreased CpG methylation of the renal p53 BstU I site promoter without affecting the Hha I or the Aci I sites. Uteroplacental insufficiency also induced a relative hypomethylation from exon 5 to exon 8, which was associated with deceased mRNA levels of DNMT1. We conclude that uteroplacental insufficiency alters p53 DNA CpG methylation, affects mRNA levels of key apoptosis-related proteins, increases renal apoptosis, and reduces glomeruli number in the IUGR kidney. We speculate that these changes represent mechanisms that contribute to the fetal origins of adult disease.
authors.affiliation: Univ. of Utah School of Medicine, Dept. of Pediatrics and Division of Neonatology, 30 North 1900 East Rm. 2A100, Salt Lake City, UT 84132-2202, USA.
authors.forename: Tho D
authors.initials: TD
authors.lastname: Pham
authors.forename: Nicole K
authors.initials: NK
authors.lastname: MacLennan
authors.forename: Christina T
authors.initials: CT
authors.lastname: Chiu
authors.forename: Gisella S
authors.initials: GS
authors.lastname: Laksana
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Hsu
authors.forename: Robert H
authors.initials: RH
authors.lastname: Lane
mesh_terms: D000818:Animals; D017209:Apoptosis; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D018899:CpG Islands / Q000502:physiology; D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000378:metabolism; D005091:Exons; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology; D020287:In Situ Nick-End Labeling; D007678:Kidney Glomerulus / Q000002:abnormalities / Q000473:pathology* / Q000503:physiopathology; D010927:Placental Insufficiency / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D011247:Pregnancy; D011401:Promoter Regions, Genetic / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000235:genetics; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D051028:bcl-2-Associated X Protein
chemical_list: C494828:Bax protein, rat; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; D015254:DNA Modification Methylases; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases